Skip to main content
Figure 5 | Molecular Pain

Figure 5

From: Resveratrol inhibits Cdk5 activity through regulation of p35 expression

Figure 5

Effects of MAP kinases and the NF-κB inhibitor on resveratrol-mediated inhibition of p35 promoter activity. Western blot analysis of the activation of MAP kinases and NF-κB signaling pathways. Protein extract from PC12 cells untreated (Control), TNF-α treated (50 ng/ml), resveratrol treated (25 μM), and TNF-α (50 ng/ml) plus resveratrol (25 μM) treated for 0, 15, 30 and 60 min (A) and 24 h (B) were analyzed by Western blot using phospho-ERK1/2, total ERK1/2, phospho-p38 MAPK, total p38 MAPK, phospho-JNK, total JNK, phospho-p65 and total p65 antibodies.

Back to article page